COVID-19 FAQ: Can we design drugs that slow down viral replication in our own cells?
COVID-19 COVID Vaccine RNA

COVID-19 FAQ: Can we design drugs that slow down viral replication in our own cells?

Simon Chapman
Simon Chapman

The coil –the genetic blueprint for replication – can misfold into unusual shapes. Since the world is still waiting for a COVID-19 vaccine, any treatment that can slow down the spread of infection would be welcome. However, our group’s investigation into these “faulty” structures suggests that these naturally occurring errors don’t exist long enough to cause a problem in viral replication on their own.

Get unlimited access to our 3-min Digests and other premium features!

Choose your plan.

Sparrow Insiders

$0 (Limited Offer)
  • Receive our daily Digest in your inbox
  • Created & reviewed by real scientists
  • Preview 380+ Digests in our library
  • Upgrade for unlimited learning
  • Unsubscribe anytime
  • Subject to availability
Join our first 25k subscribers for free! Signup Progress Bar Subscribe now for free

Sparrow Unlimited

$19 / month
  • Talk with our scientists and ask them anything
  • Access 380+ summaries anywhere, anytime
  • Listen to our premium podcast
  • Weekly newsletter of the top 5 scientific findings
  • Daily updates with new content
  • Support independent science publishing
  • No advertisement
  • Cancel anytime
Learn more Subscribe now

Sparrow Unlimited

$99 / year
  • One easy payment - save 56%
  • Talk with our scientists and ask them anything
  • Access 380+ summaries anywhere, anytime
  • Listen to our premium podcast
  • Weekly newsletter of the top 5 scientific findings
  • Daily updates with new content
  • Support independent science publishing
  • No advertisement
  • Cancel anytime
Learn more Subscribe now